Show Notes
Who has a cold, cold heart? Find out on this week’s PlayingFTSE Show!
The Steves are up the middle this week. But which FTSE 100 laggard is starting to show some life?
We’ve had another viewer request - this time to take a look at S&P 500 insurance brokers. Steve W is on the case.
Brown & Brown has been at the centre of a really interesting staff-poaching drama. But what does it mean for the stock?
Steve D’s been looking at Transmedics – again. But unlike Oppenheimer, he’s still ok with defending the stock despite a big decline.
Profits are down, but a big part of that is where they are in the investment cycle. And with a kidney device on the way, is this the time to buy?
Berkshire Hathaway’s first shareholder meeting without Warren Buffett happened last weekend. And Steve W was listening.
There’s not a lot that’s new to report – which is sort of the point. But could this be the antidote to the returns of the average investor?
Duolingo’s share price has been an AI casualty. And it’s making moves to focus on its subscriber base over profits in the short term.
That might be a smart move. But is it enough to put the stock into buying territory for either Steve at the moment?
Only on this week’s PlayingFTSE Podcast!
► Free Share + Exclusive Deals — Start Here:
🎁 Free Fractional Share — Open a Trading 212 account through our link and grab shares worth up to £/€100, completely free. Terms apply.
👉 https://www.trading212.com/Jdsfj/FTSE
When investing, your capital is at risk. Past performance doesn't guarantee future results.
📊 15% Off Fiscal.ai — The investing toolkit we actually use. Analyse stocks, spot hidden opportunities, and build income streams.
👉 https://fiscal.ai/?via=steve
► About Playing FTSE:
What's happening in the markets — and why should you care? We break down the week's biggest financial news, stocks, and economic mayhem in a way that's actually enjoyable to listen to. No jargon, no waffle, just straight-talking chat about money, markets, and the madness in between.
For people who want to get smarter about investing — without wanting to fall asleep.
► Free Investing Course + Newsletter:
📬 Join us on Substack for our completely free 10-week investing and research course — no sign-up fees, no paywalls, no nonsense. Plus regular deep dives on market trends, investor psychology, and asset classes that will genuinely make you think differently.
👉 https://playingftse.substack.com/
► Enjoyed the Episode?
☕ Buy us a coffee (we'll spend it on the show, promise): 👉 https://ko-fi.com/playingftse
💬 Drop a question in the comments or find us on Instagram: 👉 https://www.instagram.com/playing_ftse/
📩 Business enquiries: [email protected]
► Timestamps:
0:00 INTRO & OUR WEEKS 8:01 INSURANCE BROKERS / BROWN & BROWN 26:57 TRANSMEDICS 46:36 BERKSHIRE 58:55 DUOLINGO
► Show Notes:
Playing FTSE is for entertainment purposes only and does not constitute financial advice. Please consult a qualified financial professional before making investment decisions.
More from Playing FTSE
What does winning feel like? Find out on this week’s PlayingFTSE Show!
How much cheese can you buy in a Makro? Find out on this week’s PlayingFTSE Show!
Whose health is suffering along with their wealth? Find out on this week’s PlayingFTSE Show!
Who makes the best mayonnaise? Find out on this week’s PlayingFTSE Show! Steve D is back, but probably wishing he wasn’t. It’s a story of the bad and the worse in the stock market this week as the S&P 500 marches on… Shares in Vistry are down – again – after the results of the new CEO’s investigation. There’s a £400m writedown and an important change of direction for the business. Both Steves have owned this, but it’s been one set of bad news after another. And Steve D has made a big decision… Exor is a stock that has confounded value investors for some time. It trades at a huge discount to its net asset value, but could that be about to change? There’s a share buyback programme on the way and the potential for an exciting new investment. Steve W thinks this one looks interesting. It’s been a tough couple of years for Nike shareholders and the news isn’t really getting any better. Kylian Mbappe has moved to a competitor. On Running has been taking share from the market leader for some time. But with the stock now trading at the same multiples as Nike, is it worth a look at these prices? Only on this week’s PlayingFTSE Podcast!
**Check Out ISA Investor on YouTube** https://www.youtube.com/@ISAInvestorUK